| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.044 | 0.3 |